These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Gangliosides and Guillain-Barré syndrome: the Spanish data. Díez-Tejedor E; Gutiérrez-Rivas E; Gil-Peralta A Neuroepidemiology; 1993; 12(5):251-6. PubMed ID: 8309499 [TBL] [Abstract][Full Text] [Related]
3. [Recurrence of Guillain-Barre's syndrome after treatment with gangliosides]. Romero Ganuza FJ; Sebastián de la Cruz F An Med Interna; 1994 Mar; 11(3):153-4. PubMed ID: 8011883 [No Abstract] [Full Text] [Related]
4. Exposure to exogenous gangliosides and Guillain-Barré syndrome. Beghi E Neuroepidemiology; 1995; 14(2):45-8. PubMed ID: 7891813 [No Abstract] [Full Text] [Related]
5. [Clinical trials on ganglioside effectiveness]. Horga JF; Matías-Guiu J; García AG Rev Neurol; 1995; 23(122):889-95. PubMed ID: 7497258 [No Abstract] [Full Text] [Related]
6. Incidence of Guillain-Barré syndrome and ganglioside intake in Alcoi, Spain. Matias-Guiu J; Martin R; Blanquer J; Gonzalez MJ; Falip R; Oltra A; Moltó JM Neuroepidemiology; 1993; 12(1):58-60. PubMed ID: 8327024 [No Abstract] [Full Text] [Related]
7. Gangliosides and Guillain-Barré syndrome. Science supports the use of gangliosides. Massarotti M; Matano R BMJ; 1994 Mar; 308(6929):654. PubMed ID: 8074748 [No Abstract] [Full Text] [Related]
8. [Relationship between parenteral gangliosides administration and the Guillain-Barré syndrome]. Conceição I; Carvalho M; Alves M; Parreira E; Martins A; Ferro J; Sales-Luis ML Rev Neurol; 1999 Jun 1-15; 28(11):1033-5. PubMed ID: 10390766 [TBL] [Abstract][Full Text] [Related]
9. The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barré syndrome and in other neuroimmunological disorders. Enders U; Karch H; Toyka KV; Michels M; Zielasek J; Pette M; Heesemann J; Hartung HP Ann Neurol; 1993 Aug; 34(2):136-44. PubMed ID: 8338338 [TBL] [Abstract][Full Text] [Related]
10. Rapid recovery of a child with Guillain-Barré syndrome using intravenous immunoglobulins. Shah M; Weinberger M J La State Med Soc; 1998 Nov; 150(11):533-7. PubMed ID: 9861805 [TBL] [Abstract][Full Text] [Related]
11. Gangliosides and the Guillain-Barré syndrome. Landi G; Ciccone A; D'Alessandro R; Dossi BC; Ricci S; Simone IL BMJ; 1994 Jun; 308(6944):1638. PubMed ID: 8025444 [No Abstract] [Full Text] [Related]
16. [Guillain-Barré syndrome associated with anti-GQ1b antibody--nosological relationship between Fisher's syndrome and Guillain-Barré syndrome]. Jibiki T; Shimizu N; Terashima I; Yuki N Rinsho Shinkeigaku; 1994 Apr; 34(4):381-4. PubMed ID: 8026135 [TBL] [Abstract][Full Text] [Related]
17. Association of Campylobacter jejuni serotype with antiganglioside antibody in Guillain-Barré syndrome and Fisher's syndrome. Yuki N; Takahashi M; Tagawa Y; Kashiwase K; Tadokoro K; Saito K Ann Neurol; 1997 Jul; 42(1):28-33. PubMed ID: 9225682 [TBL] [Abstract][Full Text] [Related]
18. [A case of Guillain-Barré syndrome treated with intravenous high doses of immunoglobulins]. Mauro G Rev Neurol (Paris); 1989; 145(10):731-2. PubMed ID: 2510231 [TBL] [Abstract][Full Text] [Related]
19. Gangliosides and Guillain-Barré syndrome. Apparent association is a coincidence. Grigoletto F BMJ; 1994 Mar; 308(6929):653-4. PubMed ID: 8148725 [No Abstract] [Full Text] [Related]